In Vitro and in Vivo Characterization of a 18f-AlF-Labeled PSMA Ligand for Imaging of PSMA-expressing Xenografts

Journal of Nuclear Medicine - China
doi 10.2967/jnumed.118.218941
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Society of Nuclear Medicine

Related search

First 18f-Labeled Ligand for PET Imaging of uPAR: In Vivo Studies in Human Prostate Cancer Xenografts

Nuclear Medicine and Biology
Cancer ResearchNuclear MedicineRadiologyMolecular MedicineImaging
2013English

Comparison of [18F]DCFPyL and [68Ga]Ga-Psma-Hbed-Cc for PSMA-PET Imaging in Patients With Relapsed Prostate Cancer

Molecular Imaging and Biology
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2015English

Discovery of [18f]psma-7, a Novel PET-probe for the Detection of Small PSMA Positive Lesions

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2018English

In Vitro and in Vivo Evaluation of a 18f-Labeled High Affinity NOTA Conjugated Bombesin Antagonist as a PET Ligand for GRPR-Targeted Tumor Imaging

PLoS ONE
Multidisciplinary
2013English

Low Level Endogenous Prostate-Specific Membrane Antigen (PSMA) Expression in Non-Prostatic Tumor Xenografts Is Sufficient for in Vivo Tumor Targeting and Imaging

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2017English

In Vivo and in Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, 18f-Labeled Deuterated Fluorodeprenyl

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2015English

Optimization of PET Protocol and Interrater Reliability of 18f-Psma-11 Imaging of Prostate Cancer

EJNMMI Research
Nuclear MedicineRadiologyImaging
2020English

64Cu-Psma-617: A Novel PSMA-targeted Radio-Tracer for PET Imaging in Gastric Adenocarcinoma Xenografted Mice Model

Oncotarget
Oncology
2017English

Full Preclinical Validation of the 123i-Labeled Anti-Psma Antibody Fragment ScFvD2B for Prostate Cancer Imaging

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy